Pang K S, Yuen V, Fayz S, te Koppele J M, Mulder G J
Drug Metab Dispos. 1986 Jan-Feb;14(1):102-11.
The in situ perfused rat small intestine preparation was used to examine the extents of segmental absorption and metabolism of acetaminophen (A). Additionally, the preparation was employed to investigate any intestinal excretion of A and its conjugates from the circulation to the intestinal lumen. In this preparation, blood perfusate (300 ml) recirculated the intestinal preparation at 7.5 ml/min, entering via the superior mesenteric artery and returned to the reservoir via the portal vein. To demonstrate the extent of segmental absorption, metabolism, and excretion by different segments of the intestine, tracer doses of 3H-A (0.41 to 0.55 mumol in 0.3 ml of saline) were administered into the (a) entire intestine; (b) segments (first, second, and third) of one-third the length of the intestine, by instillation of the dose into the lumens of the segments; and (c) reservoir of perfusate. Exudates of luminal fluid from the injected segment and segments not exposed to drug were monitored for A and its conjugates during the experiment and at the end of 2 hr. Absorption of A was usually complete by 60 min; the extent of absorption of A at the end of 2 hr by the entire length of the intestine and by its three (first, second, and third) individual segments were 71.7 +/- 2.6, 50.5 +/- 4.0, 73.9 +/- 2.1, and 58.8 +/- 6.1% of dose (mean +/- SE), respectively. At the end of 2 hr, the total amount of acetaminophen glucuronide in perfusate and luminal fluid accounted for 3.1-5.5% and 0.14-0.1% of dose, respectively, among these preparations; acetaminophen sulfate was present only as a small percentage of dose in the lumen. Glucuronidation activity, when expressed as a percentage of the absorbed dose, was fairly constant for the entire intestine and first and second segments (8%) but decreased slightly for the third segment (7%). When A was present in blood perfusing the intestine, no metabolite was detected in perfusate or luminal fluid. Instead, unchanged A was excreted (5.6% dose) into the lumen. The effect of dose and vehicle on the extents of absorption and metabolism of A in the preparation was investigated by the instillation of different doses of A (0.16, 99.2, and 396.9 mumol in 0.3 ml of polyethene glycol 400) into the entire intestine at the duodenum.(ABSTRACT TRUNCATED AT 400 WORDS)
采用原位灌注大鼠小肠制备方法,以研究对乙酰氨基酚(A)的分段吸收及代谢程度。此外,该制备方法还用于研究A及其共轭物从循环系统到肠腔的肠道排泄情况。在此制备方法中,血液灌注液(300毫升)以7.5毫升/分钟的速度在小肠制备物中循环,经肠系膜上动脉进入,并通过门静脉返回储液器。为了证明小肠不同节段的吸收、代谢及排泄程度,将示踪剂量的³H - A(0.3毫升生理盐水中含0.41至0.55微摩尔)分别注入:(a)整个小肠;(b)小肠长度三分之一的节段(第一、第二和第三节段),通过将剂量滴入节段肠腔;(c)灌注液储液器。在实验过程中及2小时结束时,监测注入节段及未接触药物节段的肠腔液渗出物中的A及其共轭物。A的吸收通常在60分钟内完成;2小时结束时,整个小肠及其三个(第一、第二和第三)单独节段对A的吸收程度分别为剂量的71.7±2.6%、50.5±4.0%、73.9±2.1%和58.8±6.1%(平均值±标准误)。在这些制备物中,2小时结束时,灌注液和肠腔液中对乙酰氨基酚葡萄糖醛酸苷的总量分别占剂量的3.1 - 5.5%和0.14 - 0.1%;硫酸对乙酰氨基酚仅以剂量的一小部分存在于肠腔中。以吸收剂量的百分比表示时,葡萄糖醛酸化活性在整个小肠以及第一和第二节段相当恒定(8%),但在第三节段略有下降(7%)。当A存在于灌注小肠的血液中时,在灌注液或肠腔液中未检测到代谢物。相反,未变化的A排泄到肠腔中(剂量的5.6%)。通过在十二指肠将不同剂量的A(0.3毫升聚乙二醇400中含0.16、99.2和396.9微摩尔)滴入整个小肠,研究了剂量和赋形剂对该制备物中A的吸收和代谢程度的影响。(摘要截断于400字)